---
figid: PMC9519863__fcimb-12-945368-g002
figtitle: 'Gut microbiota–bile acid axis: A potential therapeutic target for liver
  fibrosis'
organisms:
- Escherichia coli
- Lactiplantibacillus plantarum
- Lacticaseibacillus casei
- Akkermansia muciniphila
- Lacticaseibacillus rhamnosus
- Lacticaseibacillus rhamnosus GG
- Ruminococcus gnavus
- Phocaeicola vulgatus
- Eubacterium rectale
- Prevotella copri
- Clostridium scindens
- Lacticaseibacillus casei str. Zhang
- Desulfovibrio desulfuricans
- Blautia obeum
- Clostridium hylemonae
- Enterocloster clostridioformis
- Alistipes finegoldii
- Eubacteriales incertae sedis
- gut metagenome
- human gut metagenome
- Ruminococcus obeum CAG39
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Hepatitis B virus
- Schistosoma japonicum
- Dioscorea communis
pmcid: PMC9519863
filename: fcimb-12-945368-g002.jpg
figlink: /pmc/articles/PMC9519863/figure/f2/
number: F2
caption: Role of bile acids in the progression of liver fibrosis. As important signaling
  molecules, bile acids can participate in liver fibrosis progression by binding to
  receptors in hepatocytes, macrophages, ileal enterocytes, and hepatic stellate cells.
  In the liver, bile acids bind to FXR and downregulate CYP7A1, CYP8B1, NTCP, and
  ASBP, and upregulate BSEP and OSTα/β via the FXR-SHP signaling pathway to the end
  of attenuating bile acid synthesis and promoting their excretion, thereby preventing
  and attenuating liver fibrosis caused by bile acid accumulation. In the ileum, bile
  acids bind to FXR to downregulate CYP7A1, CYP7B1, and CYP8B1 via the FXR-FGF19/15
  signaling pathway; VDR and PXR also play a role in regulating FGF19/15expression.
  After bile acids bind to the membrane receptor, TGR5, in addition to coordinating
  the effect of FXR, they can also activate the p38 MAPK and ERK1/2 pathways and inhibit
  the NF-κB pro-inflammatory signaling pathway to exert an antifibrotic effect. In
  contrast, bile acid binding to S1PR2 and EGFR can promote the occurrence of liver
  fibrosis via the ERK1/2 signaling pathway. Additionally, bile acids can directly
  damage the plasma membrane to activate the p38 MAPK, NF-κB, and PLA2 signaling pathways,
  resulting in an increase in reactive oxygen species levels in hepatocytes and the
  promotion of liver fibrosis. FXR, farnesoid X receptor; VDR, vitamin D receptor;
  SHP, small heterodimer partner; CYP7A1, cholesterol 7α-hydroxylase; CYP8B1, 12α-hydroxylase;
  NTCP, Na+/taurocholate cotransporting polypeptide; ABSP, apical sodium-dependent
  bile acid transporter protein; BSEP, bile salt export pump; OSTα/β, organic solute
  transporter α/β; CYP7B1, oxysterol 7α-hydroxylase; FGF19/15, fibroblast growth factor
  19/15; PXR, pregnane X receptor; TGR5, G protein-coupled receptor 5; ERK, extracellular
  signal-regulated kinase; PLA2, phospholipase A2; S1PR2, sphingosine 1-phosphate
  receptor 2; MAPK, mitogen-activated protein kinase; NF-κB, nuclear factor kappa
  B; EGFR, epidermal growth factor receptor.
papertitle: 'The gut microbiota–bile acid axis: A potential therapeutic target for
  liver fibrosis.'
reftext: Yu-Lin Zhang, et al. Front Cell Infect Microbiol. 2022;12:945368.
year: '2022'
doi: 10.3389/fcimb.2022.945368
journal_title: Frontiers in Cellular and Infection Microbiology
journal_nlm_ta: Front Cell Infect Microbiol
publisher_name: Frontiers Media S.A.
keywords: gut microbiota | bile acid | gut microbiota–bile acid axis | liver fibrosis
  | chronic liver disease
automl_pathway: 0.9635689
figid_alias: PMC9519863__F2
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
redirect_from: /figures/PMC9519863__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9519863__fcimb-12-945368-g002.html
  '@type': Dataset
  description: Role of bile acids in the progression of liver fibrosis. As important
    signaling molecules, bile acids can participate in liver fibrosis progression
    by binding to receptors in hepatocytes, macrophages, ileal enterocytes, and hepatic
    stellate cells. In the liver, bile acids bind to FXR and downregulate CYP7A1,
    CYP8B1, NTCP, and ASBP, and upregulate BSEP and OSTα/β via the FXR-SHP signaling
    pathway to the end of attenuating bile acid synthesis and promoting their excretion,
    thereby preventing and attenuating liver fibrosis caused by bile acid accumulation.
    In the ileum, bile acids bind to FXR to downregulate CYP7A1, CYP7B1, and CYP8B1
    via the FXR-FGF19/15 signaling pathway; VDR and PXR also play a role in regulating
    FGF19/15expression. After bile acids bind to the membrane receptor, TGR5, in addition
    to coordinating the effect of FXR, they can also activate the p38 MAPK and ERK1/2
    pathways and inhibit the NF-κB pro-inflammatory signaling pathway to exert an
    antifibrotic effect. In contrast, bile acid binding to S1PR2 and EGFR can promote
    the occurrence of liver fibrosis via the ERK1/2 signaling pathway. Additionally,
    bile acids can directly damage the plasma membrane to activate the p38 MAPK, NF-κB,
    and PLA2 signaling pathways, resulting in an increase in reactive oxygen species
    levels in hepatocytes and the promotion of liver fibrosis. FXR, farnesoid X receptor;
    VDR, vitamin D receptor; SHP, small heterodimer partner; CYP7A1, cholesterol 7α-hydroxylase;
    CYP8B1, 12α-hydroxylase; NTCP, Na+/taurocholate cotransporting polypeptide; ABSP,
    apical sodium-dependent bile acid transporter protein; BSEP, bile salt export
    pump; OSTα/β, organic solute transporter α/β; CYP7B1, oxysterol 7α-hydroxylase;
    FGF19/15, fibroblast growth factor 19/15; PXR, pregnane X receptor; TGR5, G protein-coupled
    receptor 5; ERK, extracellular signal-regulated kinase; PLA2, phospholipase A2;
    S1PR2, sphingosine 1-phosphate receptor 2; MAPK, mitogen-activated protein kinase;
    NF-κB, nuclear factor kappa B; EGFR, epidermal growth factor receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Nr0b2
  - Nr1h4
  - Pik3r1
  - Akt1
  - Slc10a1
  - Mapk14
  - Bas
  - Cyp8b1
  - Mapk3
  - Mapk1
  - Sphk2
  - Nfkb1
  - Cxcl2
  - Cxcr2
  - Rps6kb1
  - Nlrp3
  - Pla2g2a
  - Pla2g5
  - H2-Aa
  - Lox
  - Cox4i1
  - Tgfb1
  - Ltbp1
  - Klb
  - Parpbp
  - Ps
  - Fgf15
  - Myd88
  - Tlr4
  - Il18
  - Gpbar1
  - NR0B2
  - NR1H4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - SLC10A1
  - BAS
  - CYP8B1
  - MAPK3
  - MAPK1
  - SPHK2
  - NFKB1
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - CXCL2
  - CXCR2
  - RPS6KB1
  - RPS6KB2
  - NLRP3
  - PLA2G1B
  - PLA2G2A
  - PLA2G6
  - PLA2G3
  - PLA2G5
  - PLA2G7
  - PLA2G10
  - PLA2G12A
  - PLA2G12B
  - PLA2G2C
  - PLA2G2D
  - PLA2G2E
  - PLA2G2F
  - PLA2G4A
  - PLA2G4C
  - PLA2G4D
  - LOX
  - COX8A
  - CPOX
  - COX5A
  - COX5B
  - COX6C
  - COX7C
  - .na.character
  - COX4I1
  - COX4I2
  - COX6A1
  - COX6A2
  - COX6B1
  - COX6B2
  - COX7A1
  - COX7A2
  - COX7B
  - COX7B2
  - COX8C
  - TGFB1
  - TGFB2
  - TGFB3
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - ZNF746
  - FGF19
  - MYD88
  - TLR4
  - IL18
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - GPBAR1
  - Pik3cg
  - Errfi1
  - Prkcg
  - Fgf19
  - Irs2
  - Tnni3
---
